1-4 of 4
Marco Scarano, Sc.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Towards a Better Understanding of Epidemiology, Survival and Treatment in Myeloproliferative Neoplasms: Results of the European Leukemianet Registry (ERNEST study)

Tiziano Barbui, MD, Arianna Masciulli, MSc, PhD, Marco Scarano, Sc.D., Gianni Tognoni, Sara Sisti, Alessandra Di Lelio, Alessandro M. Vannucchi, MD, Mario Cazzola, MD, Alessandro Rambaldi, Konstanze Doehener, Francisco Cervantes, MD PhD, Francesco Passamonti, MD, Andreas Reiter, MD, Steffen Koschmieder, MD, Dietger Niederwieser, MD, Bjorn Andreasson, MD, Peter L. Johansson, MD PhD, Andreas Hochhaus, MD, Claire N. Harrison, DM, FRCP, FRCPath
Journal: Blood
Blood (2014) 124 (21): 1849.
https://doi.org/10.1182/blood.V124.21.1849.1849
Published: 2014
Journal Articles

In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Alessandro Rambaldi, MD, Alessandra Algarotti, MD, Caterina Micò, MD, Paolo Corradini, MD, Michele Falda, MD, Emilio Paolo Alessandrino, MD, Renato Fanin, MD, Elena Tagliaferri, MD, Luca Castagna, MD, Nicola Mordini, MD, Simona Sica, MD, Stella Santarone, MD, Massimo Pini, MD, Fiammetta Natalino, MD, Simona Pollichieni, BSc, Nicoletta Sacchi, PhD, BSc, Marco Scarano, Sc.D., Arianna Masciulli, BSc, Roberto Marchioli, MD, Andrea Bacigalupo, MD, Alberto Bosi, MD
Journal: Blood
Blood (2012) 120 (21): 221.
https://doi.org/10.1182/blood.V120.21.221.221
Published: 2012
Journal Articles

Chemoimmunotherapy with R-CHOP or High Dose Sequential Therapy with Autologous Stem Cell Transplantation (R-HDS) for High Risk Diffuse Large B-Cell Lymphomas Patients: Results of the Randomized R-HDS0305 Trial by Gruppo Italiano Terapie Innovative Nei Linfomi (GITIL)

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro Massimo Gianni, MD, Tiziano Barbui, MD, Marco Ladetto, MD, Anna Maria Barbui, MD, Andrea Rossi, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulé, MD, Manuela Zanni, MD, Valerio Zoli, MD, Atto Billio, MD, Andrea Gallamini, MD, Francesco Di Raimondo, MD, Andrés J.M. Ferreri, MD, Giovanni Pizzolo, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Giampietro Semenzato, MD, Maurizio Frezzato, MD, Leonardo Flenghi, MD, Marco Scarano, Sc.D., Arianna Masciulli, BSc, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 746.
https://doi.org/10.1182/blood.V120.21.746.746
Published: 2012
Journal Articles

Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis

Damiano Rondelli, MD, Judith D. Goldberg, Sc.D., Roberto Marchioli, MPH, Luis Isola, MD, Tsiporah B. Shore, MD, Josef T. Prchal, MD, Andrea Bacigalupo, MD, Alessandro Rambaldi, Rebecca B. Klisovic, MD, Vikas Gupta, MD, FRCP, FRCPath, Bjorn Andreasson, MD, Erin P. Demakos, RN, Leah S. Price, Sc.D., Marco Scarano, Sc.D., Meir Wetzler, MD, Alessandro M. Vannucchi, MD, Vesna Najfeld, PhD, Giovanni Barosi, MD, Lewis R. Silverman, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2011) 118 (21): 1750.
https://doi.org/10.1182/blood.V118.21.1750.1750
Published: 2011